反轉基因法... 於多種腸病毒疫苗之發展與應用 (Multi-Species Enterovirus Vaccine Development Using Reverse Genetics Systems)more

反轉基因法於多種腸病毒疫苗之發展與應用 (Multi-Species Enterovirus Vaccine Development Using Reverse Genetics Systems)

以三價神經... 胺酸酶抗原及其保守HCA2序列作為廣效型鼻噴流感疫苗之研究 (Trivalent Neuraminidase antigens with the universally conserved HCA2 sequence as a broad-spectrum intranasal influenza vaccine)more

以三價神經胺酸酶抗原及其保守HCA2序列作為廣效型鼻噴流感疫苗之研究 (Trivalent Neuraminidase antigens with the universally conserved HCA2 sequence as a broad-spectrum intranasal influenza vaccine)

探討克沙奇... 病毒A16型結構蛋白的位點替換對病毒特性之影響 (Site Substitution of Coxsackievirus A16 Structural Proteins Affects the Virus Characteristics)more

探討克沙奇病毒A16型結構蛋白的位點替換對病毒特性之影響 (Site Substitution of Coxsackievirus A16 Structural Proteins Affects the Virus Characteristics)

建構以重組... 腺相關病毒載體系統表現流感神經胺酸酶發展流感疫苗 (Construction of a Recombinant Adeno-Associated Virus Vector System to Express Neuraminidase and Develop Influenza Vaccines)more

建構以重組腺相關病毒載體系統表現流感神經胺酸酶發展流感疫苗 (Construction of a Recombinant Adeno-Associated Virus Vector System to Express Neuraminidase and Develop Influenza Vaccines)

第二b型忌... 熱型腸毒素作為黏膜佐劑增強保護性免疫對抗H5N1禽流感病毒 (Type IIb Heat Labile Enterotoxin B Subunit as a Mucosal Adjuvant to Enhance Protective Immunity against H5N1 Avian Influenza Viruses)more

第二b型忌熱型腸毒素作為黏膜佐劑增強保護性免疫對抗H5N1禽流感病毒 (Type IIb Heat Labile Enterotoxin B Subunit as a Mucosal Adjuvant to Enhance Protective Immunity against H5N1 Avian Influenza Viruses)

結合大腸桿... 菌忌熱型腸毒素第二B型A次單元與神經胺酸酶融合蛋白之小鼠噴鼻式疫苗開發 (Intranasal immunization with Type IIb E.coli Heat-Labile Enterotoxin A Subunit and Neuraminidase fusion protein for Influenza vaccine development)more

結合大腸桿菌忌熱型腸毒素第二B型A次單元與神經胺酸酶融合蛋白之小鼠噴鼻式疫苗開發 (Intranasal immunization with Type IIb E.coli Heat-Labile Enterotoxin A Subunit and Neuraminidase fusion protein for Influenza vaccine development)

鼻噴免疫重... 組神經胺酸酶蛋白對抗A型與B型流感病毒感染 (Intranasal immunization with recombinant neuraminidase proteins against influenza A and B virus infection)more

鼻噴免疫重組神經胺酸酶蛋白對抗A型與B型流感病毒感染 (Intranasal immunization with recombinant neuraminidase proteins against influenza A and B virus infection)

開發高效能... 次單位疫苗對抗新型冠狀病毒感染之研究 (Studies of Developing High Efficacy Subunit Vaccine Against SARS-CoV-2 Infection)more

開發高效能次單位疫苗對抗新型冠狀病毒感染之研究 (Studies of Developing High Efficacy Subunit Vaccine Against SARS-CoV-2 Infection)

結合新冠肺... 炎及流感似病毒顆粒疫苗之開發 (Development of COVID-19 and Influenza Combination VLP Vaccine)more

結合新冠肺炎及流感似病毒顆粒疫苗之開發 (Development of COVID-19 and Influenza Combination VLP Vaccine)

醣遮蔽於流... 感病毒神經胺酸酶引起廣效性神經酸胺酶抑制抗體 (Glycan masking of Neuraminidase antigen elicited broadly reactive neuraminidase inhibiting antibodies against influenza viruses)more

醣遮蔽於流感病毒神經胺酸酶引起廣效性神經酸胺酶抑制抗體 (Glycan masking of Neuraminidase antigen elicited broadly reactive neuraminidase inhibiting antibodies against influenza viruses)

以去醣化與... 醣遮蔽棘蛋白抗原開發次世代新冠疫苗 (Use of Deglycaned and Glycan-Masked Spike Proteins for Next-Generation COVID-19 Vaccine Development)more

以去醣化與醣遮蔽棘蛋白抗原開發次世代新冠疫苗 (Use of Deglycaned and Glycan-Masked Spike Proteins for Next-Generation COVID-19 Vaccine Development)

肺炎黴漿菌... 感染分子分型分析與檢測試劑研發 (Development of serological test methods and molecular typing of Mycoplasma pneumoniae)more

肺炎黴漿菌感染分子分型分析與檢測試劑研發 (Development of serological test methods and molecular typing of Mycoplasma pneumoniae)

醣遮蔽棘蛋... 白技術開發第三代新冠肺炎疫苗抗原 (Glycan-Masking the Spike Antigen of SARS-CoV-2 for Third-Generation Vaccine COVID-19 Vaccine Development)more

醣遮蔽棘蛋白技術開發第三代新冠肺炎疫苗抗原 (Glycan-Masking the Spike Antigen of SARS-CoV-2 for Third-Generation Vaccine COVID-19 Vaccine Development)

以重組血凝... 素與神經胺酸酶蛋白噴鼻免疫開發H7N9禽流感疫苗 (Intranasal Immunizations with Recombinant Neuraminidase and Hemagglutinin Proteins for H7N9 Avian Influenza Vaccine Development)more

以重組血凝素與神經胺酸酶蛋白噴鼻免疫開發H7N9禽流感疫苗 (Intranasal Immunizations with Recombinant Neuraminidase and Hemagglutinin Proteins for H7N9 Avian Influenza Vaccine Development)

以新型冠狀... 病毒棘突蛋白受體結合區融合大腸桿菌第二型b型忌熱型腸毒素A次單元開發鼻噴型新冠肺炎黏膜疫苗 (Intranasal immunization with the receptor-binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit for COVID-19 mucosal vaccine development)more

以新型冠狀病毒棘突蛋白受體結合區融合大腸桿菌第二型b型忌熱型腸毒素A次單元開發鼻噴型新冠肺炎黏膜疫苗 (Intranasal immunization with the receptor-binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit for COVID-19 mucosal vaccine development)

流感病毒神... 經胺酸酶370 loop突變對於其酵素活性、血凝素與神經胺酸酶平衡、小鼠毒性、以及其去活化病毒疫苗之免疫反應研究 (Characterization of the influenza virus neuraminidase 370-loop mutations for NA enzyme activity, HA-NA balancing, mouse virulence, and inactivated virus immunogenicity.)more

流感病毒神經胺酸酶370 loop突變對於其酵素活性、血凝素與神經胺酸酶平衡、小鼠毒性、以及其去活化病毒疫苗之免疫反應研究 (Characterization of the influenza virus neuraminidase 370-loop mutations for NA enzyme activity, HA-NA balancing, mouse virulence, and inactivated virus immunogenicity.)

含機能性脂... 質之奈米乳液對於樹突狀細胞的免疫調節作用 (Immunomodulatory Effect of Nanoemulsions Based on Functional Hydrocarbons on Dendritic Cells)more

含機能性脂質之奈米乳液對於樹突狀細胞的免疫調節作用 (Immunomodulatory Effect of Nanoemulsions Based on Functional Hydrocarbons on Dendritic Cells)

茲卡病毒膜... 蛋白第三區域與鞭毛素融合蛋白分子工程應用於噴鼻式疫苗開發 (Molecular engineering of flagellin fusion with Zika virus envelope protein domain III for intranasal vaccine development)more

茲卡病毒膜蛋白第三區域與鞭毛素融合蛋白分子工程應用於噴鼻式疫苗開發 (Molecular engineering of flagellin fusion with Zika virus envelope protein domain III for intranasal vaccine development)

亞洲眼鏡蛇... 毒之蛋白質體分析與新型抗蛇毒血清研發 (Study on Venom Proteome of Asiatic Cobras and its Application on Novel Antivenom Development)more

亞洲眼鏡蛇毒之蛋白質體分析與新型抗蛇毒血清研發 (Study on Venom Proteome of Asiatic Cobras and its Application on Novel Antivenom Development)

A型流感神... 經胺酸酶之唾液酸結合區與其誘發神經胺酸酶抑制性抗體之研究 (The secondary sialic acid binding site of influenza A viruses on virus neuraminidase and the elicitation of neuraminidase-inhibiting antibodies)more

A型流感神經胺酸酶之唾液酸結合區與其誘發神經胺酸酶抑制性抗體之研究 (The secondary sialic acid binding site of influenza A viruses on virus neuraminidase and the elicitation of neuraminidase-inhibiting antibodies)

設計具多重... 弗林切位點之重組茲卡類病毒顆粒疫苗 (Recombinant Zika virus-like particles containing a multiple furin cleavage site for vaccine design)more

設計具多重弗林切位點之重組茲卡類病毒顆粒疫苗 (Recombinant Zika virus-like particles containing a multiple furin cleavage site for vaccine design)

茲卡病毒套... 膜第三區域重組蛋白與黏膜佐劑之疫苗研發 (Zika virus envelope domain III recombinant proteins formulated with mucosal adjuvants for vaccine development)more

茲卡病毒套膜第三區域重組蛋白與黏膜佐劑之疫苗研發 (Zika virus envelope domain III recombinant proteins formulated with mucosal adjuvants for vaccine development)

擠壓程序對... 於乳液粒子之粒徑分佈影響以及鼻黏膜疫苗遞送之研究 (A study on the effects of the extrusion process on the size distribution of emulsified particles and the intranasal delivery of vaccine)more

擠壓程序對於乳液粒子之粒徑分佈影響以及鼻黏膜疫苗遞送之研究 (A study on the effects of the extrusion process on the size distribution of emulsified particles and the intranasal delivery of vaccine)

結合APR... IL或BAFF之高免疫性多價流感類病毒顆粒疫苗 (High immunogenic influenza virus-like particles containing APRIL or BAFF for multi-subtype vaccine development)more

結合APRIL或BAFF之高免疫性多價流感類病毒顆粒疫苗 (High immunogenic influenza virus-like particles containing APRIL or BAFF for multi-subtype vaccine development)

腺病毒載體... 表現茲卡病毒套膜蛋白之疫苗研發 (Vaccine development of Zika envelope protein expressed by adenovirus-vector)more

腺病毒載體表現茲卡病毒套膜蛋白之疫苗研發 (Vaccine development of Zika envelope protein expressed by adenovirus-vector)

利用大腸桿... 菌暨熱型腸毒素融合蛋白用於禽流感次單位疫苗的開發 (Application of recombinant fusion protein vaccine against influenza virus)more

利用大腸桿菌暨熱型腸毒素融合蛋白用於禽流感次單位疫苗的開發 (Application of recombinant fusion protein vaccine against influenza virus)

以H5N1... 禽流感神經胺酸酶重組蛋白免疫誘導交叉性神經胺酸酶抑制性抗體之研究 (Mapping cross-reactive epitopes for NA inhibiting antibodies elicited by H5N1 NA protein immunizations)more

以H5N1禽流感神經胺酸酶重組蛋白免疫誘導交叉性神經胺酸酶抑制性抗體之研究 (Mapping cross-reactive epitopes for NA inhibiting antibodies elicited by H5N1 NA protein immunizations)

結合醣遮蔽... 與去醣基化策略應用於創新型血凝素流感疫苗之設計 (A Combination of Glycan Masking and Glycan Unmasking Strategies as A Novel Influenza Hemagglutinin Vaccine Design)more

結合醣遮蔽與去醣基化策略應用於創新型血凝素流感疫苗之設計 (A Combination of Glycan Masking and Glycan Unmasking Strategies as A Novel Influenza Hemagglutinin Vaccine Design)

以神經胺酸... 酶重組蛋白免疫引發交叉性抑制抗體之抗原表位研究 (Dissecting cross-reactive epitopes for the induction of NA-inhibiting antibodies via recombinant NA protein immunizations)more

以神經胺酸酶重組蛋白免疫引發交叉性抑制抗體之抗原表位研究 (Dissecting cross-reactive epitopes for the induction of NA-inhibiting antibodies via recombinant NA protein immunizations)

Devel... opment of immunofocusing virus-like particles as broadly protective influenza vaccines (以免疫聚焦性類病毒顆粒研製廣效性流感疫苗)more

Development of immunofocusing virus-like particles as broadly protective influenza vaccines (以免疫聚焦性類病毒顆粒研製廣效性流感疫苗)

開發重組H... 7N9血凝素禽流感黏膜疫苗 (Studies of recombinant HA proteins with different adjuvants for avian influenza H7N9 mucosal vaccine development)more

開發重組H7N9血凝素禽流感黏膜疫苗 (Studies of recombinant HA proteins with different adjuvants for avian influenza H7N9 mucosal vaccine development)

利用醣遮蔽... 與去醣基化血凝素之類病毒顆粒引發H5N1禽流感廣效性中和抗體 (Influenza virus-like particles by glycan masking and unmasking of hemagglutinin antigens to induce broadly neutralizing antibodies against H5N1 avian influenza viruses)more

利用醣遮蔽與去醣基化血凝素之類病毒顆粒引發H5N1禽流感廣效性中和抗體 (Influenza virus-like particles by glycan masking and unmasking of hemagglutinin antigens to induce broadly neutralizing antibodies against H5N1 avian influenza viruses)

以減毒活病... 毒、腺病毒載體及套膜蛋白第三區域融合蛋白 作為第二、四型登革疫苗之免疫性研究 (Immunization studies for dengue serotype 2/4 vaccines using live-attenuated virus, adenoviral vector and envelope domain III fusion protein)more

以減毒活病毒、腺病毒載體及套膜蛋白第三區域融合蛋白 作為第二、四型登革疫苗之免疫性研究 (Immunization studies for dengue serotype 2/4 vaccines using live-attenuated virus, adenoviral vector and envelope domain III fusion protein)

新穎性神經... 氨酸酶突變蛋白以提升異源型流感病毒之神經氨酸酶抑制性抗體與免疫保護力 (Novel Neuraminidase Mutants Proteins to Enhance Heterosubtypic NA-Inhibiting Antibodies and cross-protective immunity against influenza A virus)more

新穎性神經氨酸酶突變蛋白以提升異源型流感病毒之神經氨酸酶抑制性抗體與免疫保護力 (Novel Neuraminidase Mutants Proteins to Enhance Heterosubtypic NA-Inhibiting Antibodies and cross-protective immunity against influenza A virus)

H7N9禽... 流感血凝素之 重組蛋白、腺病毒載體與類病毒顆粒之 免疫性研究 (Immunogenicity of recombinant protein, adenovirus vector and virus-like particles of the avian-origin influenza H7N9 virus hemagglutinin)more

H7N9禽流感血凝素之 重組蛋白、腺病毒載體與類病毒顆粒之 免疫性研究 (Immunogenicity of recombinant protein, adenovirus vector and virus-like particles of the avian-origin influenza H7N9 virus hemagglutinin)

利用禽流感... H5N1及新興流感pH1N1之神經胺酸脢重組蛋白誘導神經胺酸脢抑制性抗體及保護性免疫力之研究 (Neuraminidase-inhibiting antibodies and protective immunity elicited by recombinant neuraminidase proteins of H5N1 and pH1N1 Influenza A Viruses)more

利用禽流感H5N1及新興流感pH1N1之神經胺酸脢重組蛋白誘導神經胺酸脢抑制性抗體及保護性免疫力之研究 (Neuraminidase-inhibiting antibodies and protective immunity elicited by recombinant neuraminidase proteins of H5N1 and pH1N1 Influenza A Viruses)

利用腺病毒... 載體及第三區域套膜蛋白融合重組鞭毛蛋白進行prime-boost免疫法研發四價登革熱疫苗 (Prime-boost immunization using adenovirus vector and envelope domain III protein fused with flagellin for tetravalent dengue vaccine development)more

利用腺病毒載體及第三區域套膜蛋白融合重組鞭毛蛋白進行prime-boost免疫法研發四價登革熱疫苗 (Prime-boost immunization using adenovirus vector and envelope domain III protein fused with flagellin for tetravalent dengue vaccine development)

移除A型流... 感病毒血凝素軀幹部N-linked醣基以誘發異型中和性抗體與交叉保護免疫性之研究 (Removal of N-linked glycan(s) in the stem region of influenza A virus hemagglutinin proteins to elicit heterosubtypic neutralizing antibodies and cross-protective immunity)more

移除A型流感病毒血凝素軀幹部N-linked醣基以誘發異型中和性抗體與交叉保護免疫性之研究 (Removal of N-linked glycan(s) in the stem region of influenza A virus hemagglutinin proteins to elicit heterosubtypic neutralizing antibodies and cross-protective immunity)

探討乳液配... 方的分散性質對於抗原遞送以及疫苗免疫生成性的影響 (A study on the dispersion properties of emulsion formulations affecting the antigen delivery and vaccine immunogenicity)more

探討乳液配方的分散性質對於抗原遞送以及疫苗免疫生成性的影響 (A study on the dispersion properties of emulsion formulations affecting the antigen delivery and vaccine immunogenicity)